Literature DB >> 28478548

Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.

C Cusini1, L Sassi1, G De Paola1, E Piantanida2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28478548     DOI： 10.1007/s40618-017-0678-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  High doses of biotin in chronic progressive multiple sclerosis: a pilot study.

Authors:  Frédéric Sedel; Caroline Papeix; Agnès Bellanger; Valérie Touitou; Christine Lebrun-Frenay; Damien Galanaud; Olivier Gout; Olivier Lyon-Caen; Ayman Tourbah
Journal:  Mult Scler Relat Disord       Date:  2015-01-24       Impact factor: 4.339

2.  Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.

Authors:  Giuseppe Barbesino
Journal:  Thyroid       Date:  2016-04-28       Impact factor: 6.568

Review 3.  Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Authors:  L Bartalena; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2016-06-18       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.